Sofinnova Partners vet Tordjman launches Jeito with €200M first biotech fund

Paris-based Jeito Capital launched Monday with the €200 million ($223.1 million) close of its first fund, which the firm will

Read the full 200 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE